CCM
AMGN icon

CAAS Capital Management’s Amgen AMGN Stock Holding History

CAAS Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,050
Closed -$1.01M – 1028
2021
Q1 		$1.01M Buy
+4,050
New +$966K 0.01% 768
2020
Q4 		– Sell
-4,000
Closed -$1.02M – 826
2020
Q3 		$1.02M Buy
+4,000
New +$991K 0.02% 341

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

CAAS Capital Management's AMGN Position: Q2 2021 in Review

CAAS Capital Management sold out of Amgen (AMGN) in Q2 2021, closing a stake of 4,050 shares — an estimated $1.01M sold.

CAAS Capital Management first reported a position in AMGN in Q3 2020 and held it in 2 quarters. The position peaked at $1.02M in Q3 2020. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • CAAS Capital Management reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
  • CAAS Capital Management sold 4,050 Amgen shares in Q2 2021, an estimated $1.01M.
  • CAAS Capital Management first reported a position in Amgen in Q3 2020 and held it in 2 quarters.
  • CAAS Capital Management's Amgen position peaked at $1.02M in Q3 2020.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on CAAS Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.